Some of the recent and new update from WHO CNS tumor 2016
1) For astrocytic and oligodendroglial tumor IDH immunohistochemistry is must now
2) New entity diffuse midline glioma,H3 K 27M mutant is added
3) New variants of glioblastoma are giant cell and epitheloid glioblastoma
4) New entity added in ependymoma is RELA fusion positive ependymoma
5) Mesulloblastoma is classified into 4 classes based on WNT and SHH activated pathway
#NimhansCNSupdate